Encompass Health Corp
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $EHC in the last 30 days.
See all $EHC insider activity →Encompass Health (EHC) declared a $0.21 per share quarterly dividend, matching its previous payout. The forward yield is 0.7%. The dividend is payable on January 15 to shareholders of record on January 4, with an ex-dividend date of January 4.
Encompass Health is opening a 50-bed rehabilitation hospital in Bangor, Maine, the state's first new hospital in over 30 years. The facility, set to open in early October, will serve patients recovering from serious injuries. Encompass Health, the largest owner of rehab hospitals in the U.S., invested over $60 million in the project, which addresses high demand for rehab services in Maine.
Encompass Health (EHC) reported Q2 revenue of $1.597B, up 9.6%, and adjusted EPS of $1.55, up 10.7%. The company raised full-year guidance for revenue, EBITDA, and EPS. It also increased its stock repurchase authorization to $1B. Patient volume and revenue per discharge grew, but free cash flow fell due to higher capital spending. Long-term debt rose to $2.598B.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning EHC (Encompass Health Corp). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent EHC coverage spans financial news, corporate actions and earnings.
Dividend announcement may attract income-focused investors and cause modest price adjustment around ex‑dividend date.
The new facility expands Encompass Health's footprint in a high‑demand market, potentially boosting future revenue and earnings.
Guidance lift suggests stronger demand and pricing power, likely supporting the stock price in the near term.
Earnings beat and higher guidance support a bullish outlook, while the larger buyback adds upside potential.
The insider sale represents a modest $630k divestment by a senior executive, adding to a pattern of net insider selling at the company.
AlphAI scores every news story that mentions EHC with an AI model for sentiment and relevance, and aggregates insider trades from Encompass Health Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Encompass Health (EHC) declared a $0.21 per share quarterly dividend, matching its previous payout. The forward yield is 0.7%. The dividend is payable on January 15 to shareholders of record on January 4, with an ex-dividend date of January 4.
1 min readEncompass Health is opening a 50-bed rehabilitation hospital in Bangor, Maine, the state's first new hospital in over 30 years. The facility, set to open in early October, will serve patients recovering from serious injuries. Encompass Health, the largest owner of rehab hospitals in the U.S., invested over $60 million in the project, which addresses high demand for rehab services in Maine.
2 min readEncompass Health (EHC) reported Q2 revenue of $1.597B, up 9.6%, and adjusted EPS of $1.55, up 10.7%. The company raised full-year guidance for revenue, EBITDA, and EPS. It also increased its stock repurchase authorization to $1B. Patient volume and revenue per discharge grew, but free cash flow fell due to higher capital spending. Long-term debt rose to $2.598B.
2 min readEncompass Health (EHC) reported adjusted EPS of $1.55, raised its 2026 outlook, and increased its share buyback program to $1B. The company plans to open new hospitals and add beds, signaling confidence in long-term demand. Analysts project $7.9B revenue and $806.1M earnings by 2029, a 22% upside from current prices. Labor shortages remain a key risk.
2 min readEncompass Health Corp (EHC) Chief Accounting Officer Andrew Price sold 5,211 shares at $120.93 each, totaling $630,000, leaving him with 69,483 shares. This follows a year of insider selling with no buying, raising questions about near-term prospects. The stock is fairly valued, trading 4.8% above its GF Value estimate.
1 min readPrice Andrew L (Chief Accounting Officer) sold 5,211 shares of Encompass Health Corp (EHC) at $120.93 ($0.63M total) on 2026-08-31.
1 min readDarby John Patrick (EVP, Gen Counsel & Secretary) sold 4,858 shares of Encompass Health Corp (EHC) at $121.09 ($0.59M total) on 2026-08-31.
1 min readEncompass Health Corporation (EHC) is expanding capacity to address high occupancy and meet demand, targeting 6-8% discharge growth. Plans include 6-10 new hospitals annually, 150-200 beds at existing sites, and small-format facilities starting 2027. North Carolina's repeal of Certificate of Need requirements is a long-term catalyst. EHC has financial flexibility with 1.9X net leverage and a $1 billion share repurchase program, but faces labor and reimbursement risks.
2 min readEncompass Health (EHC) has gained 13.9% over six months, outperforming its industry. The company, with a $12B market cap, operates 176 inpatient rehab hospitals. Its forward P/E is 18.92X, below the industry average. Earnings estimates for 2026 are $6.04 per share, up 10.8% YoY, with revenue expected at $6.5B, up 8.8% YoY. EHC has beaten earnings estimates for four consecutive quarters, with an average surprise of 6.8%. The company is expanding capacity and improving staff retention, but faces r
3 min readEncompass Health reported revenue growth of about 10% to $1.6 billion and raised full-year guidance, along with dividend and $1 billion buyback authorization, after which shares rose near a 52-week high. On the same day, CFO Scott Coltharp trimmed his stake, selling a smaller portion than CEO Mark Tarr. Investors may view the sales alongside the earnings update.
3 min read
